Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises EQT Infrastructure VI on its public offer for OX2
Mandate

Vinge advises EQT Infrastructure VI on its public offer for OX2

May 13, 2024 Capital Markets and Public M&A M&A EU, Competition and Regulatory Banking and Finance Real Estate and Construction Employment and Benefits Data protection and processing of personal data Corporate Crime & Compliance

EQT Infrastructure VI, through its indirectly owned subsidiary Otello BidCo AB, announces a recommended public offer to the shareholders of OX2 AB (publ) (“OX2”). The shares are admitted to trading on Nasdaq Stockholm, Large Cap.

OX2, founded in 2004, is a leading renewable energy platform with a large and diverse project portfolio across all major renewable energy technologies (onshore and offshore wind, solar, and storage) and is today one of the largest developers of onshore wind in Europe.

The total value of the offer is approximately SEK 16.4 billion.

Vinge’s team mainly consists of Sofie Bjärtun, Erik Sjöman, Linnéa Sellström, Joel Magnusson, Lorin Arabi and Maximilian Bengtsson (apital Markets and Public M&A), Christoffer Thalin, Peter Sundgren, Filip Öhrner, Daniel Daun, Niklas Törnell and Jonatan Karlsson (Energy, M&A), Sebastian Örndahl, Hampus Peterson, Lovisa Lewin and Ebba Ehrling Sjögren (Regulatory), Kamyar Najmi (Banking and finance), Lina Österberg, Tilda Hall and Agnes Pigg (Environment and Real Estate) Sam Seddigh and Alice Göransson (Employment), Fredrika Hjelmberg and Ian Linde (IT/GDPR), Gulestan Ali (Compliance) and Julia Ulander Kull (Transaction Support Coordinator).

 

Related

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

 Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge advises Studentbostäder i Norden AB (publ) in connection with its issuance of bonds in an amount of SEK 500 million and its early redemption of outstanding bonds

 Vinge has advised Studentbostäder i Norden AB (publ) in connection with its issuance of senior unsecured bonds in an amount of SEK 500 million (within a framework of SEK 750 million) and in parallel with the company's voluntary early redemption of previously issued bonds.
March 12, 2026